Vanda Pharmaceuticals reported $59.71M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 78.11M 11.79M
Acorda Therapeutics ACOR:US USD 23M 7.07M
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Akebia Therapeutics AKBA:US USD 30.92M 1.89M
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Anika Therapeutics ANIK:US USD 21.28M 8K
Arrowhead Research ARWR:US USD 31.62M 1.11M
AstraZeneca AZN:LN USD 3.35B 280M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Clovis Oncology CLVS:US USD 30.38M 2.21M
Eli Lilly And LLY:US USD 1.64B 29M
Enanta Pharmaceuticals ENTA:US USD 12.57M 360K
Esperion Therapeutics ESPR:US USD 24.95M 4.65M
Halozyme Therapeutics HALO:US USD 34.07M 23.41M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Insmed INSM:US USD 75.58M 15.61M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Johnson & Johnson JNJ:US USD 6.51B 423M
Lexicon Pharmaceuticals LXRX:US USD 12.58M 1.89M
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Merk MRK:US USD 2.63B 134M
Minerva Neurosciences NERV:US USD 2.84M 6.57K
Moderna Inc MRNA:US USD 278M 67M
Novartis NVS:US USD 3.7B 295M
Pfizer PFE:US USD 4.87B 1.33B
Ptc Therapeutics PTCT:US USD 80.12M 226K
Puma Biotechnology PBYI:US USD 23.96M 3.38M
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Takeda 4502:JP JPY 262.3B 13.57B
Teva Pharmaceutical TEVA:IT USD 777M 72M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
Vanda Pharmaceuticals VNDA:US USD 59.71M 26.71M
Veracyte VCYT:US USD 42.73M 2.77M